Ameritas Advisory Services LLC cut its position in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 4.1% during the 4th quarter, Holdings Channel reports. The firm owned 2,047 shares of the company’s stock after selling 88 shares during the quarter. Ameritas Advisory Services LLC’s holdings in Elevance Health were worth $755,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in ELV. Pathway Financial Advisers LLC raised its stake in shares of Elevance Health by 51,967.1% during the 3rd quarter. Pathway Financial Advisers LLC now owns 657,607 shares of the company’s stock worth $341,956,000 after purchasing an additional 656,344 shares during the period. Stifel Financial Corp increased its holdings in Elevance Health by 309.7% during the third quarter. Stifel Financial Corp now owns 713,027 shares of the company’s stock worth $370,794,000 after buying an additional 538,978 shares during the last quarter. International Assets Investment Management LLC raised its position in Elevance Health by 85,533.1% in the third quarter. International Assets Investment Management LLC now owns 532,638 shares of the company’s stock worth $276,972,000 after acquiring an additional 532,016 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in Elevance Health by 16.2% in the third quarter. Massachusetts Financial Services Co. MA now owns 2,397,258 shares of the company’s stock valued at $1,246,574,000 after acquiring an additional 334,552 shares during the last quarter. Finally, Wellington Management Group LLP grew its position in shares of Elevance Health by 6.9% during the 3rd quarter. Wellington Management Group LLP now owns 4,461,585 shares of the company’s stock valued at $2,320,024,000 after acquiring an additional 286,905 shares during the period. 89.24% of the stock is owned by institutional investors.
Elevance Health Trading Up 0.3 %
Shares of ELV stock opened at $390.21 on Thursday. Elevance Health, Inc. has a 52-week low of $362.21 and a 52-week high of $567.26. The business’s fifty day moving average is $386.73 and its 200 day moving average is $464.16. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.50 and a current ratio of 1.50. The company has a market capitalization of $90.50 billion, a PE ratio of 14.23, a price-to-earnings-growth ratio of 1.09 and a beta of 0.84.
Analyst Ratings Changes
Elevance Health Profile
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Featured Stories
- Five stocks we like better than Elevance Health
- About the Markup Calculator
- Oracle Announces Game-Changing News for the AI Industry
- Trading Stocks: RSI and Why it’s Useful
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV – Free Report).
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.